Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Biomarker Discovery

Background:

• Heart failure (HF) is a major global health burden, characterized by impaired cardiac function.
• Cardiac fibrosis, involving abnormal extracellular matrix remodeling, significantly drives HF progression and severity.
• Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in cardiac pathological processes.

Purpose of the Study:

• To review recent advancements in understanding ncRNAs' role in cardiac fibrosis.
• To evaluate the potential of ncRNAs as biomarkers for assessing heart failure severity.
• To discuss the implications of ncRNAs in the development of cardiac fibrosis.

Main Methods:

• Critical examination of existing literature and recent findings on ncRNAs in HF.
• Analysis of studies investigating the link between ncRNAs and cardiac fibrosis.
• Review of evidence supporting ncRNAs' presence in peripheral blood as potential biomarkers.

Main Results:

• Growing evidence suggests ncRNAs are involved in cardiac remodeling, particularly fibrosis.
• ncRNAs are detectable in peripheral blood, offering a non-invasive approach for HF assessment.
• Specific ncRNAs are implicated in the mechanisms driving myofibroblast activation and matrix deposition.

Conclusions:

• ncRNAs represent a promising class of biomarkers for heart failure.
• Understanding ncRNA involvement in fibrosis can lead to novel diagnostic and therapeutic strategies for HF.
• Further research is warranted to validate ncRNAs as reliable biomarkers for HF stratification and management.